Regulation of hepatic cholesterol synthesis by a novel protein (SPF) that accelerates cholesterol biosynthesis

FASEB Journal

Volumn 20, Issue 14, 2006, Pages

  Shibata, Norihito ^a,b   Jishage, Kou Ichi ^c   Arita, Makoto ^a   Watanabe, Miho ^c   Kawase, Yosuke ^c   Nishikawa, Kiyotaka ^d   Natori, Yasuhiro ^d   Inoue, Hiroyasu ^e   Shimano, Hitoshi ^f   Yamada, Nobuhiro ^f   Tsujimoto, Masafumi ^b   Arai, Hiroyuki ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b RIKEN   (Japan)

^c Chugai Research Institute for Medical Science Inc   (Japan)

^d NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^e NARA WOMEN'S UNIVERSITY   (Japan)

^f UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Fasting; Fibrate; Peroxisome proliferator activated receptor ; Squalene monooxygenase

Indexed keywords

CARRIER PROTEINS AND BINDING PROTEINS; CHOLESTEROL; FIBRIC ACID DERIVATIVE; HYPOCHOLESTEROLEMIC AGENT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST; SUPERNATANT PROTEIN FACTOR; TRIACYLGLYCEROL; ANTILIPEMIC AGENT; CARRIER PROTEIN; CLOFIBRIC ACID; LIPOPROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; TOCOPHEROL ASSOCIATED PROTEIN, MOUSE; TOCOPHEROL-ASSOCIATED PROTEIN, MOUSE; TRANSACTIVATOR PROTEIN;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL LIVER LEVEL; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; DRUG EFFECT; FOOD DEPRIVATION; GENE EXPRESSION REGULATION; GENETICS; LIVER; METABOLISM; MOUSE MUTANT;

ANIMALS; ANTILIPEMIC AGENTS; CARRIER PROTEINS; CHOLESTEROL; CLOFIBRIC ACID; FOOD DEPRIVATION; GENE EXPRESSION REGULATION; LIPOPROTEINS; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PPAR ALPHA; TRANS-ACTIVATORS;

EID: 33845639955     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.06-6368fje     Document Type: Article

References (46)

1. Kersten, S., Seydoux, J., Peters, J. M., Gonzalez, F. J., Desvergne, B., and Wahli, W. (1999) Peroxisome proliferator-activated receptor α mediates the adaptive response to fasting. J. Clin. Invest. 103, 1489-1498
2. Nwokoro, N. A., Wassif, C. A., and Porter, F. D. (2001) Genetic disorders of cholesterol biosynthesis in mice and humans. Mol. Genet. Metab. 74, 105-119
3. Porter, J. A., Young, K. E., and Beachy, P. A. (1996) Cholesterol modification of hedgehog signaling proteins in animal development. Science 274, 255-259
4. Goldstein, J. L., and Brown, M. S. (1990) Regulation of the mevalonate pathway. Nature 343, 425-430
5. Horton, J. D., Bashmakov, Y., Shimomura, I., and Shimano, H. (1998) Regulation of sterol regulatory element binding proteins in livers of fasted and refed mice. Proc. Natl. Acad. Sci. U. S. A. 95, 5987-5992
6. Engelking, L. J., Kuriyama, H., Hammer, R. E., Horton, J. D., Brown, M. S., Goldstein, J. L., and Liang, G. (2004) Overexpression of Insig-1 in the livers of transgenic mice inhibits SREBP processing and reduces insulin-stimulated lipogenesis. J. Clin. Invest. 113, 1168-1175
7. Wiss, O. (1976) Influence of fasting and cholesterol feeding on the cholesterol synthesis in rats in vivo. Biochem. Biophys. Res. Commun. 68, 353-357
8. Newberry, E. P., Xie, Y., Kennedy, S., Han, X., Buhman, K. K., Luo, J., Gross, R. W., and Davidson, N. O. (2003) Decreased hepatic triglyceride accumulation and altered fatty acid uptake in mice with deletion of the liver fatty acid-binding protein gene. J. Biol. Chem. 278, 51664-51672
9. Tchen, T. T., and Bloch, K. (1957) On the conversion of squalene to lanosterol in vitro. J. Biol. Chem. 226, 921-930
10. Ferguson, J. B., and Bloch, K. (1977) Purification and properties of a soluble protein activator of rat liver squalene epoxidase. J. Biol. Chem. 252, 5381-5385
11. Shibata, N., Arita, M., Misaki, Y., Dohmae, N., Takio, K., Ono, T., Inoue, K., and Arai, H. (2001) Supernatant protein factor, which stimulates the conversion of squalene to lanosterol, is a cytosolic squalene transfer protein and enhances cholesterol biosynthesis. Proc. Natl. Acad. Sci. U. S. A. 98, 2244-2249
12. Friedlander, E. J., Caras, I. W., Lin, L. F., and Bloch, K. (1980) Supernatant protein factor facilitates intermembrane transfer of squalene. J. Biol. Chem. 255, 8042-8045
13. Yagi, T., Nada, S., Watanabe, N., Tamemoto, H., Kohmura, N., Ikawa, Y., and Aizawa, S. (1993) A novel negative selection for homologous recombinants using diphtheria toxin A fragment gene. Anal. Biochem. 214, 77-86
14. Kaempf-Rotzoll, D. E., Horiguchi, M., Hashiguchi, K., Aoki, J., Tamai, H., Linderkamp, O., and Arai, H. (2003) Human placental trophoblast cells express α-tocopherol transfer protein. Placenta 24, 439-444
15. Liscum, L., Luskey, K. L., Chin, D. J., Ho, Y. K., Goldstein, J. L., and Brown, M. S. (1983) Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase and its mRNA in rat liver as studied with a monoclonal antibody and a cDNA probe. J. Biol. Chem. 258, 8450-8455
16. Yokota, T., Igarashi, K., Uchihara, T., Jishage, K-I., Tomita, H., Inaba, A., Li, Y., Arita, M., Suzuki, H., Mizusawa, H., and Arai, H. (2001) Delayed-onset ataxia in mice lacking α-tocopherol transfer protein: model for neuronal degeneration caused by chronic oxidative stress. Proc. Natl. Acad. Sci. U. S. A. 98, 15185-15190
17. Schwarz, M., Russell, D. W., Dietschy, J. M., and Turley, S. D. (1998) Marked reduction in bile acid synthesis in cholesterol 7α-hydroxylase- deficient mice does not lead to diminished tissue cholesterol turnover or to hypercholesterolemia. J. Lipid Res. 39, 1833-1843
18. Sobel, A. E., and Mayer, A. M. (1945) Improvements in the Schoenheimer-Sperry method for the determination of free cholesterol. J. Biol. Chem. 157, 255-264
19. Sperry, W. M., and Webb, M. (1950) A revision of the Schoenheimer-Sperry method for cholesterol determination. J. Biol. Chem. 187, 97-106
20. Dietschy, J. M., and Siperstein, M. D. (1967) Effect of cholesterol feeding and fasting on sterol synthesis in seventeen tissues of the rat. J. Lipid Res. 8, 97-104
21. Tsukamoto, K., Smith, P., Glick, J. M., and Rader, D. J. (1997) Liver-directed gene transfer and prolonged expression of three major human ApoE isoforms in ApoE-deficient mice. J. Clin. Invest. 100, 107-114
22. Ohashi, K., Osuga, J., Tozawa, R., Kitamine, T., Yagyu, H., Sekiya, M., Tomita, S., Okazaki, H., Tamura, Y., and Yahagi, N., et al. (2003) Early embryonic lethality caused by targeted disruption of the 3-hydroxy-3- methylglutaryl-CoA reductase gene. J. Biol. Chem. 278, 42936-42941
23. Leone, T. C., Weinheimer, C. J., and Kelly, D. P. (1999) A critical role for the peroxisome proliferator-activated receptor α (PPARα) in the cellular fasting response: the PPARα-null mouse as a model of fatty acid oxidation disorders. Proc. Natl. Acad. Sci. U. S. A. 96, 7473-7478
24. Chawla, A., Repa, J. J., Evans, R. M., and Mangelsdorf, D. J. (2001) Nuclear receptors and lipid physiology: opening the X-files. Science 294, 1866-1870
25. Horton, J. D., Goldstein, J. L., and Brown, M. S. (2002) SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 109, 1125-1131
26. Peet, D. J., Turley, S. D., Ma, W., Janowski, B. A., Lobaccaro, J-M. A., Hammer, R. E., and Mangelsdorf, D. J. (1998) Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXRα. Cell 93, 693-704
27. Grundy, S. M., and Vega, G. L. (1987) Fibric acids: effects on lipids and lipoprotein metabolism. Am. J. Med. 83, 9-20
28. Olivier, P., Plancke, M. O., Marzin, D., Clavey, V., Sauzieres, J., and Fruchart, J. C. (1988) Effects of fenofibrate, gemfibrozil and nicotinic acid on plasma lipoprotein levels in normal and hyperlipidemic mice. A proposed model for drug screening. Atherosclerosis 70, 107-114
29. Berthou, L., Duverger, N., Emmanuel, F., Langouet, S., Auwerx, J., Guillouzo, A., Fruchart, J. C., Rubin, E., Denefle, P., Staels, B., and Branellec, D. (1996) Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice. J. Clin. Invest. 97, 2408-2416
30. Cohen, B. I., Raicht, R. F., Shefer, S., and Mosbach, E. H., (1974) Effects of clofibrate on sterol metabolism in the rat. Biochim. Biophys. Acta. 369, 79-85
31. Van den Berghe, G. (1991) The role of the liver in metabolic homeostasis: implications for inborn errors of metabolism. J. Inherit. Metab. Dis. 14, 407-420
32. Singh, D. K., Mokashi, V., Elmore, C. L., and Porter, T. D. (2003) Phosphorylation of supernatant protein factor enhances its ability to stimulate microsomal squalene monooxygenase. J. Biol. Chem. 278, 5646-5651
33. Mokashi, V., and Porter, T. D. (2005) Supernatant protein factor requires phosphorylation and interaction with Golgi to stimulate cholesterol synthesis in hepatoma cells. Arch. Biochem. Biophys. 435, 175-181
34. Bankir, L., Martin, H., Dechaux, M., and Ahloulay, M. (1997) Plasma cAMP: a hepatorenal link influencing proximal reabsorption and renal hemodynamics? Kidney Int. Suppl. 59, S50-S56
35. Bahnsen, M., Burrin, J. M., Johnston, D. G., Pernet, A., Walker, M., and Alberti, K. G. (1984) Mechanisms of catecholamine effects on ketogenesis. Am. J. Physiol. 247, E173-E180
36. Mardones, P., Pilon, A., Bouly, M., Duran, D., Nishimoto, T., Arai, H., Kozarsky, K. F., Altayo, M., Miquel, J. F., and Luc, G., et al. (2003) Fibrates down-regulate hepatic scavenger receptor class B type I protein expression in mice. J. Biol. Chem. 278, 7884-7890
37. Haas, M. J., Reinacher, D., Pun, K., Wong, N. C., and Mooradian, A. D. (2000) Induction of the apolipoprotein AI gene by fasting: a relationship with ketosis but not with ketone bodies. Metabolism 49, 1572-1578
38. Kok, T., Wolters, H., Bloks, V. W., Havinga, R., Jansen, P. L., Staels, B., and Kuipers, F. (2003) Induction of hepatic ABC transporter expression is part of the PPARα-mediated fasting response in the mouse. Gastroenterology 124, 160-171
39. Ishikawa, T., and Fidge, N. (1979) Changes in the concentration of plasma lipoproteins and apoproteins following the administration of Triton WR 1339 to rats. J. Lipid Res. 20, 254-264
40. Mokashi, V., Singh, D. K., and Porter, T. D. (2005) Supernatant protein factor stimulates HMG-CoA reductase in cell culture and in vitro. Arch. Biochem. Biophys. 433, 474-480
41. Brown, A. S., Bakker-Arkema, R. G., Yellen, L., Henley, R. W. Jr., Guthrie, R., Campbell, C. F., Koren, M., Woo, W., McLain, R., and Black, D. M. (1998) Treating patients with documented atherosclerosis to National Cholesterol Education Program-recommended low-density-lipoprotein cholesterol goals with atorvastatin, fluvastatin, lovastatin and simvastatin. J. Am. Coll. Cardiol. 32, 665-672
42. Hiyoshi, H., Yanagimachi, M., Ito, M., Ohtsuka, I., Yoshida, I., Saeki, T., and Tanaka, H. (2000) Effect of ER-27856, a novel squalene synthase inhibitor, on plasma cholesterol in rhesus monkeys: comparison with 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors. J. Lipid Res. 41, 1136-1144
43. Ozdemir, O., Boran, M., Gokce, V., Uzun, Y., Kocak, B., and Korkmaz, S. (2000) A case with severe rhabdomyolysis and renal failure associated with cerivastatin-gemfibrozil combination therapy - a case report. Angiology 51, 695-697
44. Shek, A., and Ferrill, M. J. (2001) Statin-fibrate combination therapy. Ann. Pharmacother. 35, 908-917
45. Chang, J. T., Staffa, J. A., Parks, M., and Green, L. (2004) Rhabdomyolysis with HMG-CoA reductase inhibitors and gem-fibrozil combination therapy. Pharmacoepidemiol. Drug. Saf. 13, 417-426
46. Brown, M. S., and Goldstein, J. L. (1997) The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 89, 331-340